Overview

A Study Comparing PF-05089771 TS Capsule To PF-05089771 TS Oral Dispersion In The Fasted State

Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to estimate the relative bioavailability and food effect of a PF-05089771 capsule.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer